| http://purl.uniprot.org/citations/27418135 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/27418135 | http://www.w3.org/2000/01/rdf-schema#comment | "Application of tumor genome sequencing has identified numerous loss-of-function alterations in cancer cells. While these alterations are difficult to target using direct interventions, they may be attacked with the help of the synthetic lethality (SL) approach. In this approach, inhibition of one gene causes lethality only when another gene is also completely or partially inactivated. The EPHB6 receptor tyrosine kinase has been shown to have anti-malignant properties and to be downregulated in multiple cancers, which makes it a very attractive target for SL applications. In our work, we used a genome-wide SL screen combined with expression and interaction network analyses, and identified the SRC kinase as a SL partner of EPHB6 in triple-negative breast cancer (TNBC) cells. Our experiments also reveal that this SL interaction can be targeted by small molecule SRC inhibitors, SU6656 and KX2-391, and can be used to improve elimination of human TNBC tumors in a xenograft model. Our observations are of potential practical importance, since TNBC is an aggressive heterogeneous malignancy with a very high rate of patient mortality due to the lack of targeted therapies, and our work indicates that FDA-approved SRC inhibitors may potentially be used in a personalized manner for treating patients with EPHB6-deficient TNBC. Our findings are also of a general interest, as EPHB6 is downregulated in multiple malignancies and our data serve as a proof of principle that EPHB6 deficiency may be targeted by small molecule inhibitors in the SL approach."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.org/dc/terms/identifier | "doi:10.18632/oncotarget.10569"xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Li Y."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Zhang Z."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Anderson D.H."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Vizeacoumar F.J."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Freywald A."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Gerger C."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Kanthan R."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Paul J.M."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Freywald T."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Bhanumathy K.K."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Vizeacoumar F.S."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "El Zawily A."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Mousseau D."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/author | "Toosi B."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/date | "2016"xsd:gYear |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/name | "Oncotarget"xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/pages | "50027-50042"xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/title | "Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment."xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://purl.uniprot.org/core/volume | "7"xsd:string |
| http://purl.uniprot.org/citations/27418135 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/27418135 |
| http://purl.uniprot.org/citations/27418135 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/27418135 |
| http://purl.uniprot.org/uniprot/#_A0A0G2JNC5-mappedCitation-27418135 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/27418135 |